|
Anogen-YES
Biotech was founded in 1989.
In
2004, Anogen-YES Biotech, along with Asia United Antibody and
Dalian Tianwei Pharmaceutical, purchased a 38,000 square foot
GMP facility for the large scale production of ABCream and other
monoclonal antibodies. This new facility was called Asia
Space Pharmaceutical Co. Ltd.
In
2007, Anogen-YES Biotech has established Suzhou YES Biotech and Xuzhou YES Biotech in P.R.China. These two companies are focusing on anti-chemokine therapy to infectious diseases and
Alzheimer's disease.
Anogen
is continually seeking to foster professional partnerships with
corporate and research associates in order to expand our
expertise in antibody-based technologies.
If
you are interested in a joint venture with Anogen, please
contact info@anogen.ca.
|
